The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Presentation just finished. Institutions focus was on the US acquisition Avantis and the 2 US contracts which we didn't get. They were also hard on cash flow which had bumps. To me they were making mountains out of potholes but these guys know the company better than any retail investor so these are 2 areas to look at more closely. Company points at massive increase in the global order book and surprisingly mentioned that there is stuff hidden from public view for various reasons. Nobody doubts that but I am surprised it was vocalised.
On that pont I note this on Telegram 'The British defense company QinetiQ will transfer 10 more Talon sapper robots to Ukraine. Before the start of the full-scale war with the Russian Federation, we already had 12 such assistants These robots will demine ...'
Maybe Mo needs to write a few numbers on a white board for my old brain to absorb.
Did I hear correctly that ALL existing beds will be closed during 2024 and we will have 50 or are will QM 31ish beds still be available in addition to the 50 at CW?
The 2022 update (thanks Bazza) lists 3 site and a total of 62 beds. I do have a coffee in my hand but either my little grey cells are failing to engage warp drive this morning or my cloth ears are fooling me again. My 1950s vintage arithmetic is giving me vintage trouble. It doesn't handle increases from 62 to 50 with facility. Pour me another barkeep.
Thanks for the swift reply Bazzaman.
My vague impression after years of hearing about new beds after new beds was that we were already near 50 beds. Only 24 is a reality check for me.
The 120 figure is me plucking a number out the air of where I imagine we could be in a few years. Whether 120 or 75 my point would be the same, is 70 going to be a hard ceiling to break? However since we are starting from only 24 beds the point does now seem something of an old man's fantasy. That new reality will need another coffee to bed into my psyche.
Can someone please remind me what current bed capacity is? I'm lying in bed wondering how easy the expansion from 70 to 120 will be. Canary Wharf may be cheap today but that will change. I look forward to hearing details of the lease and who shares the building with us.
A key feature of the design seems to be that each bed will be an independent zone allowing greater flexibility and opportunities to run parallel trials.
All beds on 1 floor plus bigger better labs should make life better for staff. Lots of positives make the move to 1 site a no brained. My only reservation is that I don't associate Canary Wharf with cheap rents and friendly landlords.
Previous statements suggested that AH has not seriously considered the Philippines. Now he has a decision to make. The licence expires soon so he needs to get a grip in a hurry. What are the requirements for a further licence extension? We can't develop all 3 areas.
The bars and pool tables probably don't have anything to entice AH so the only hard facts guiding his thoughts will be based on the mining economics. The additional costs and risks of exploring outside Oz are significant. The economic case for holding will have to be overwhelming. But is there a competitive market for Philippine gold assets now?
Thanks. I will look seriously at these ETFs but I prefer closed end funds which don't need to sell holdings when sentiment turns against them. My view after 45 years investing and advising:- PE is not suitable for an ETF. Youngsters who can keep on top of their holdings may make illiquid ETFs work for them, but I'm old and I can't keep up.
Fully agree with your view that food giants will clean up in this space. Thai Union (owner of JohnWest) invested serious money in CellAgriculture, as did Nestle.
I like Anic's idea of investing in IP which the giants will pick up and licence. Patents may become very valuable.
Now I will go digging into your suggestions.
Further ideas welcomed.
The Mystrry Machine has been investigating if not trolling.
The term "UK based" may mean no more than the company is registered in Sheffield. The RNS says Peak Nickel ltd has NO assets. Therefore it has no licence, no claims. Hopefully we paid a pile of cash for something but the RNS is deliberately not helpful.
The suggestion of a SW Scotland nickel mine is interesting but what is that suggestion based on? A few tons were extracted as a trial but ithat mine didn't really get going. I also see an unwelcome reference to ****nic in the area.
The 3rd director, Lockwood, lives in Canada. There are claims called Nickel Peak in BC but they they were acquired by SKRR in October 22. Another blind alley.
The 2 McKenzie directors are also directors of Peak Minerals Ltd. My spirits rose when I found that Peak Minerals Ltd holds 5 copper projects in Western Australia. But it's a completely different Peak Minerals. Nothing to do with the Mackenzies.
I parked The Mystery Machine for the night. Hopefully someone here will point out that I have misread the RNS. The best spin I can see is that the location of the target is being kept secret because they don't yet hold any claim or title. There must be a target. They're going to drill something.
The wall of money going in to battery storage is one of the hottest parts of the broader infrastructure story. In some ways we are in the same situation as the young Andrew Carnegie. An entirely new industry must be built. The world needs vast amounts of long term, safe battery storage. As long as Bushveld doesn't screw up it will be a major player supplying and enabling a fundamental global industry which doe not yet exist. The Force is with us.
Rewatched the presentation and I like what I heard. Good upside potential and level headed management with both a plan and a resource. Been a (small) holder for years and happy to wait for Phalaborwa to deliver.
Pro forma adjustments are poorly named. They are meant to move us onto a like for like basis. Kape made a major acquisition during the year so big adjustments are required to get like for like.
Kape seems to have done very well to integrate express vpn and make good progress towards realising potential synergies. Turning promise and potential into money in the bank is very difficult. Hats off to Erlichman. These accounts show a great start has been made with every indication that more synergies will follow.
As a hairy bloke I really don't understand STC but I do understand mkting. A JV and licensing agreement with a recognised name makes lots of sense. A trade sale looks premature.
AIM doesn't have many profitable companies with a growing cash mountain. I'm with the 99.9% of shareholders who will wait patiently for a stream of dividends.
Demand for Orph's services can only grow. Expectations have been raised but promising drugs still have an 85% failure rate in clinical trials. The arithmetic of resting promising drugs is becoming clearer.
My fear is that a pharma giant snaps up Orph at a bargain price. I guess that, at present, keeping Orph independent adds value to trial results and provides some protection from takeover. However ar some point the Mercks of this world will want these skills in house.
In a recent webcast CF commented they were working to find a mechanism which would prevent or limit the benefits of immediately selling after the exD date. Hats off if he succeeds but I can't think of a previous example.
People in the water industry used to have to sign the Official Secrets Act. I guess they probably still do so don't expect to see anything in the press. That doesn't mean there isn't concern, there's just no pressure to address the problems. It does mean that DVRG is probably better looking for sales outside the UK. Hence GB has been selling to the USA and China. Both nations are xenophobic at State level so we need production bases in both countries in order to make meaningful progress. China is coming along. In the USA where labor laws are onerous we may need to partner with a US manufacturer.
Cash per share $177.75
At current values the business is almost free
Whether CF aimed his barbs at Leo or at himself, Beaulieu correctly highlights that CF regrets the way the accounts were presented. The normal vanilla stat accounts presentation failed to disclose the turnaround which had been achieved. A supplementary breakdown together with post year end results would have helped., but the auditor may not have wanted this additional unaudited information to be provided with the accounts. CF should have found an alternative way to present the story, but he was juggling several balls, syringes, the odd spitoon and a family at the time.
Next month may put that story far behind us. I added again this morning. I have confidence